Table 5.

Adverse events.

	Pitavastatin n = 54 (%)	Control n = 54 (%)	p
Hemorrhagic events
Intracerebral hemorrhage	1 (1.9)	0 (0)	0.32
Gastrointestinal hemorrhage	0 (0)	2 (3.7)	0.12
Hepatic enzymes increase	0 (0)	2 (3.7)	0.12
Rhabdomyolysis	2 (3.7)	0 (0)	0.12
Myositis	2 (3.7)	0 (0)	0.12
Overall events	5 (9.3)	4 (7.4)	0.40